Tobias Seibel

Low-Dose Irradiation Programs Macrophage Differentiation to an iNOS+/M1 Phenotype that Orchestrates Effective T Cell Immunotherapy

Felix Klug, Hridayesh Prakash, Peter E. Huber et al. · Cancer Cell · 2013 · 1.1K citations · Full text

Life Sciences, Cell Biology, Immunology +16

Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancer

Alexandros Papachristofilou, M. Hipp, Ute Klinkhardt et al. · Journal for ImmunoTherapy of Cancer · 2019 · 222 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Swarm learning for decentralized artificial intelligence in cancer histopathology

Oliver Lester Saldanha, Philip Quirke, Nicholas P. West et al. · Nature Medicine · 2022 · 209 citations · Full text

Computing, Computer Science, Oncology +15

Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial

Peter G. Kremsner, Rodolfo Andrés Ahuad Guerrero, Eunate Arana‐Arri et al. · The Lancet Infectious Diseases · 2021 · 175 citations · Full text

Veterinary Medicine, Infectious Diseases, Molecular Virology +16

Results of the randomized, placebo-controlled phase I/IIB trial of CV9104, an mRNA based cancer immunotherapy, in patients with metastatic castration-resistant prostate cancer (mCRPC)

Arnulf Stenzl, S. Feyerabend, Isabel Syndikus et al. · Annals of Oncology · 2017 · 68 citations

Medicine, Immunology, Oncology +16